ATE135576T1 - Anxiolytisch wirksame piperazinderivate - Google Patents

Anxiolytisch wirksame piperazinderivate

Info

Publication number
ATE135576T1
ATE135576T1 AT88201970T AT88201970T ATE135576T1 AT E135576 T1 ATE135576 T1 AT E135576T1 AT 88201970 T AT88201970 T AT 88201970T AT 88201970 T AT88201970 T AT 88201970T AT E135576 T1 ATE135576 T1 AT E135576T1
Authority
AT
Austria
Prior art keywords
piperazine derivatives
anxiolytic
properties
dosages
blood
Prior art date
Application number
AT88201970T
Other languages
English (en)
Inventor
Jan Hartog
Johannes Mos
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Application granted granted Critical
Publication of ATE135576T1 publication Critical patent/ATE135576T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
AT88201970T 1987-09-11 1988-09-09 Anxiolytisch wirksame piperazinderivate ATE135576T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8702167 1987-09-11

Publications (1)

Publication Number Publication Date
ATE135576T1 true ATE135576T1 (de) 1996-04-15

Family

ID=19850597

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88201970T ATE135576T1 (de) 1987-09-11 1988-09-09 Anxiolytisch wirksame piperazinderivate

Country Status (13)

Country Link
US (1) US4889852A (de)
EP (1) EP0307061B1 (de)
JP (1) JP2749593B2 (de)
AT (1) ATE135576T1 (de)
AU (1) AU618279B2 (de)
CA (1) CA1327163C (de)
DE (1) DE3855121T2 (de)
DK (1) DK172628B1 (de)
ES (1) ES2085852T3 (de)
GR (1) GR3019544T3 (de)
IE (1) IE74200B1 (de)
IL (1) IL87712A (de)
ZA (1) ZA886694B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74200B1 (en) * 1987-09-11 1997-07-16 Duphar Int Res Anxiolytically active piperazine derivatives
US5219855A (en) * 1988-01-29 1993-06-15 Mitsubishi Kasei Corporation Anxiolytic drug
US4983612A (en) * 1989-10-05 1991-01-08 American Home Products Corporation Antihypertensive benzopyran derivatives
US5162324A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie Naphyl piperazines useful as 5-HT1A receptor ligands
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE182367T1 (de) * 1992-12-21 1999-08-15 Duphar Int Res Enzymatisches verfahren zur stereoselektiven herstellung einem enantiomer aus einem hetero bicyclischen alkohols
CA2453837C (en) * 2001-07-20 2011-10-04 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder using eltoprazine and related compounds
US9066903B2 (en) 2006-02-28 2015-06-30 The United States Of America As Represented By The Department Of Veterans Affairs Pharmacological treatment of Parkinson's disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
DE3571436D1 (en) * 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
IE74200B1 (en) * 1987-09-11 1997-07-16 Duphar Int Res Anxiolytically active piperazine derivatives

Also Published As

Publication number Publication date
IL87712A0 (en) 1989-02-28
IE882697L (en) 1989-03-11
JPH01100169A (ja) 1989-04-18
ZA886694B (en) 1989-06-28
JP2749593B2 (ja) 1998-05-13
EP0307061A3 (de) 1991-07-17
IL87712A (en) 1992-12-01
DK172628B1 (da) 1999-08-02
AU618279B2 (en) 1991-12-19
AU2207688A (en) 1989-05-11
GR3019544T3 (en) 1996-07-31
EP0307061A2 (de) 1989-03-15
DK497288A (da) 1989-03-12
EP0307061B1 (de) 1996-03-20
DK497288D0 (da) 1988-09-07
DE3855121T2 (de) 1996-08-22
DE3855121D1 (de) 1996-04-25
CA1327163C (en) 1994-02-22
ES2085852T3 (es) 1996-06-16
US4889852A (en) 1989-12-26
IE74200B1 (en) 1997-07-16

Similar Documents

Publication Publication Date Title
BG92804A (bg) 4-бензоилизоксазолови производни
LU90944I2 (fr) Dérivés pipérazinyl-héterocycliques
DE69027235D1 (de) Xanthinderivate
DE3855121D1 (de) Anxiolytisch wirksame Piperazinderivate
FI881609A (fi) Dihydropyridinamider, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
ZA893346B (en) Anticoagulant peptide alcohols
DK382788D0 (da) 4-amino-substituerede 1,2-dihydroxy-naphthalen-derivater
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
AP8800109A0 (en) "Heterocyclic insecticides".
OA07768A (fr) Dérivés d'anillines fongicides.
OA08746A (fr) Dérivés d'acide hydrocinnamique.
DE3882959D1 (de) Thiazolidinderivate, ihre herstellung und anti-amnesie-zusammensetzungen, die sie enthalten.
ES2061749T3 (es) Compuestos heterociclicos y agentes antiulcerosos.
ES2058196T3 (es) Derivados de azacromano.
NZ229300A (en) Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
ES2039273T3 (es) Compuestos antimicoticos a base de combinaciones de nicomicina y azol antimicotico.
ES2073919T3 (es) Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo.
DE3268605D1 (en) 3,7a-diazacyclohepta(j,k)fluorene derivatives, their preparation and therapeutical use
FI882388A (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
ES2067461T3 (es) Derivados isoprenoides y agentes anti-ulcerosos que contienen los mismos.
FR2618781B2 (fr) Procede de preparation de derives de la 4,4-dimethyl tetrahydro pyr-2-one
PH25608A (en) 3-amino-tetrahydro-isoquinoline
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee